Insider Transactions in Q4 2024 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Stephen F. Betz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,331
+3.16%
|
$2,331
$1.91 P/Share
|
|
Dec 02
2024
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
10,000
-9.09%
|
$570,000
$57.57 P/Share
|
|
Nov 22
2024
|
Jeff E. Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
501
-0.96%
|
$28,056
$56.52 P/Share
|
|
Oct 03
2024
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
14,375
-33.52%
|
$776,250
$54.63 P/Share
|
|
Oct 03
2024
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,375
+25.11%
|
$230,000
$16.89 P/Share
|